Tenet Healthcare (NYSE:THC) EVP Paola Arbour Sells 6,500 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 6,500 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Tenet Healthcare Price Performance

Shares of THC opened at $227.79 on Friday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The company has a 50 day moving average price of $213.46 and a 200-day moving average price of $203.99. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $247.21. The stock has a market capitalization of $19.81 billion, a PE ratio of 14.71, a PEG ratio of 1.11 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. During the same period last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD grew its position in Tenet Healthcare by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock worth $1,488,484,000 after purchasing an additional 119,809 shares during the last quarter. Boston Partners raised its holdings in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after buying an additional 494,581 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock valued at $448,419,000 after buying an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the period. Finally, Norges Bank purchased a new position in Tenet Healthcare in the 4th quarter worth $248,494,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. Mizuho increased their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research report on Thursday. UBS Group lifted their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Finally, Leerink Partners raised their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $250.56.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.